See the DrugPatentWatch profile for Trastuzumab
How much does trastuzumab deruxtecan cost in India?
Price information for trastuzumab deruxtecan in India isn’t provided in the source material available here. DrugPatentWatch.com typically tracks patents and market exclusivity, and it may list manufacturer/brand and related market data, but it does not reliably provide a single, official “India price” figure across pack sizes and supply channels.
If you share the brand name you’re asking about (for example, Enhertu or another local listing), the pack size (mg per vial) and whether you mean “per vial” or “per cycle,” I can narrow the search terms and help you interpret typical cost ranges that depend on dosing.
Which brand is usually sold in India?
Trastuzumab deruxtecan is most commonly associated with the brand Enhertu in many markets. India availability can vary by strength (mg per vial) and packaging, which affects the final bill because dosing is weight-based and calculated per treatment cycle.
What drives the final out-of-pocket cost in India?
Even when the unit price is known, total cost can change based on:
- How many vials are needed per cycle (depends on the prescribed dose and patient weight)
- Hospital/injectable administration fees and consumables
- Whether there are patient-assistance programs or oncology reimbursement support (if applicable)
Patent/exclusivity angles that can affect future pricing
Pricing in India can also shift when exclusivity ends or when additional manufacturers enter. For current patent and exclusivity context, DrugPatentWatch.com is a useful reference:
- https://www.drugpatentwatch.com/
If you want, I can help you get an exact figure
Send any of the following and I’ll help you pinpoint the right number to use:
1) Brand name (and strength, if listed)
2) Price you found (and where: hospital pharmacy vs online)
3) Dose prescribed and cycle schedule (e.g., every 3 weeks)
Sources
- https://www.drugpatentwatch.com/